SC
CRL icon

Syon Capital’s Charles River Laboratories CRL Stock Holding History

Syon Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$598K Sell
3,464
-367
-10% -$68K 0.03% 486
2025
Q4 		$764K Sell
3,831
-579
-13% -$105K 0.04% 394
2025
Q3 		$690K Buy
4,410
+2,252
+104% +$358K 0.04% 373
2025
Q2 		$327K Buy
2,158
+470
+28% +$62.7K 0.02% 514
2025
Q1 		$254K Buy
+1,688
New +$283K 0.02% 473

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Syon Capital's CRL Position: Q1 2026 in Review

Syon Capital reduced its Charles River Laboratories (CRL) stake by 9.6% in Q1 2026, selling an estimated $68K and leaving 3,464 shares worth $598K. The position accounts for 0.03% of the portfolio, ranked #486.

Syon Capital first reported a position in CRL in Q1 2025 and has held it in 5 quarters since. The position peaked at $764K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Syon Capital held 3,464 shares of Charles River Laboratories worth $598K as of Q1 2026.
  • Syon Capital sold 367 Charles River Laboratories shares in Q1 2026, an estimated $68K.
  • Charles River Laboratories made up 0.03% of Syon Capital's portfolio in Q1 2026, its #486 holding.
  • Syon Capital first reported a position in Charles River Laboratories in Q1 2025 and has held it in 5 quarters since.
  • Syon Capital's Charles River Laboratories position peaked at $764K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.